Growth Metrics

Novartis Ag (NVS) Treasury Shares (2016 - 2026)

Novartis Ag's Treasury Shares history spans 13 years, with the latest figure at -$47.0 million for Q1 2026.

  • On a quarterly basis, Treasury Shares fell 147.37% to -$47.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$47.0 million, a 147.37% decrease, with the full-year FY2025 number at -$50.0 million, up 5.66% from a year prior.
  • Treasury Shares hit -$47.0 million in Q1 2026 for Novartis Ag, up from -$50.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for NVS hit a ceiling of $92.0 million in Q4 2022 and a floor of -$70.0 million in Q3 2022.
  • Historically, Treasury Shares has averaged -$29.7 million across 5 years, with a median of -$40.0 million in 2024.
  • Biggest five-year swings in Treasury Shares: soared 91.67% in 2022 and later crashed 229.27% in 2024.
  • Tracing NVS's Treasury Shares over 5 years: stood at $92.0 million in 2022, then crashed by 55.43% to $41.0 million in 2023, then crashed by 229.27% to -$53.0 million in 2024, then rose by 5.66% to -$50.0 million in 2025, then increased by 6.0% to -$47.0 million in 2026.
  • Business Quant data shows Treasury Shares for NVS at -$47.0 million in Q1 2026, -$50.0 million in Q4 2025, and -$44.0 million in Q3 2025.